Literature DB >> 8833046

The natural history of rheumatoid arthritis.

F Wolfe1.   

Abstract

The natural history of rheumatoid arthritis (RA) is best defined by a combination of disease specific measures such as radiographs and remission rates, and patient specific measures such as functional and work disability, total joint replacement, adverse drug reactions, social disruption and premature mortality. Prognosis depends largely on how RA is defined, since clinical RA has a worse and epidemiologic RA a better prognosis. Seronegative polyarthritis confounds the assessment of RA since it has a better prognosis for remission and longterm outcome. RA is a progressive disease in the clinic, particularly in patients with longterm followup. Ongoing cohort studies of recent onset RA may aid in our understanding of RA prognosis, but may still beg the question, what is RA?

Entities:  

Mesh:

Year:  1996        PMID: 8833046

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  19 in total

1.  Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists.

Authors:  J Sany; P Bourgeois; A Saraux; S Durieux; A Lafuma; J P Daurès; F Guillemin; J Sibilia
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 2.  [Treat to target and personalized medicine (precision medicine)].

Authors:  J Detert; G R Burmester
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

3.  Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis.

Authors:  M Heliövaara; K Aho; P Knekt; O Impivaara; A Reunanen; A Aromaa
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

4.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

5.  Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.

Authors:  H Singh; V Gupta; S Ray; H Kumar; P Talapatra; M Kaur; S Kumar; S Arya; R Mathur; N Ghangas
Journal:  Clin Rheumatol       Date:  2012-09-15       Impact factor: 2.980

6.  Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey.

Authors:  D Aletaha; G Eberl; V P K Nell; K P Machold; J S Smolen
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

7.  Immunoglobulin subtypes predict therapy response to the biologics in patients with rheumatoid arthritis.

Authors:  Meryem Can; Ahu Najip; Neslihan Yılmaz; Nevsun Inanc; Sule Yavuz
Journal:  Rheumatol Int       Date:  2012-11-21       Impact factor: 2.631

8.  Inhibition of cathepsin B by Au(I) complexes: a kinetic and computational study.

Authors:  Shamila S Gunatilleke; Cesar Augusto F de Oliveira; J Andrew McCammon; Amy M Barrios
Journal:  J Biol Inorg Chem       Date:  2008-05       Impact factor: 3.358

9.  An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.

Authors:  Annette H M van der Helm-van Mil; Rachel Knevel; Guy Cavet; Tom W J Huizinga; Douglas J Haney
Journal:  Rheumatology (Oxford)       Date:  2013-01-03       Impact factor: 7.580

10.  Correlation Between Level of Interleukin-37 and Rheumatoid Arthritis Progression.

Authors:  Jifeng Zhu; Chuanjiang Xie; Hongjiu Qiu; Ling Shi
Journal:  Int J Gen Med       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.